Brownstein Hyatt Farber Schreck Adds Six to Expanding IP Group

Brownstein Hyatt Farber Schreck Adds Six to Expanding IP Group

PDF

Brownstein’s Intellectual Property Team Now One of the Largest in the West

Brownstein Hyatt Farber Schreck continues to expand its Intellectual Property Group with the addition of six new members to the team. The new attorneys include Paul J. Prendergast, Cara Crowley-Weber, Ajay Singh and Barton W. Emery, along with paralegal Sheri Fisher. The group previously worked for the law firm Merchant & Gould. In addition, attorney Rita Wu joins Brownstein from the law firm Arnold & Porter. With its existing intellectual property team, including the 13 team members that joined during late 2013, Brownstein’s intellectual property practice is now among the largest in the West.

"This group augments our existing patent expertise and broadens the intellectual property services that we can offer our clients,” said Adam Agron, co-managing partner of the firm. “They bring a sophisticated and experienced national patent practice focused on biotechnology, chemicals, pharmaceuticals and consumer goods to our existing mechanical and electrical engineering patent practice."

This team counsels clients on many aspects of intellectual property from identification, protection and management of intellectual property assets to preparing and prosecuting patent applications, enforcing intellectual property rights through litigation and providing infringement and patentability opinions.

Prendergast and Crowley-Weber’s practices focus on counseling clients in the biotechnology and chemical practice areas. They have extensive experience in various aspects of intellectual property law, including U.S. and foreign patent prosecution, freedom to operate opinions, invalidity and non-infringement opinions, licensing agreements, and overall due diligence reviews. Prendergast and Crowley-Weber work closely with clients to manage their patent portfolios and develop holistic business strategies. Prendergast obtained his PhD from the University of Colorado Health Sciences Center in experimental pathology. Crowley-Weber obtained her PhD from the University of Arizona Health Sciences Center in microbiology and immunology, with a minor in pharmacology and toxicology.

Wu's practice focuses on developing and managing strategic patent portfolios, preparing and prosecuting domestic and foreign patent applications, due diligence, and drafting non-infringement, invalidity or freedom-to-operate opinions. Her experience spans a broad range of technical fields and is concentrated in the biological, biotechnological, pharmaceutical and chemical arts. Prior to receiving her law degree, Wu was a scientific advisor at Fitzpatrick, Cella, Harper and Scinto, a leading intellectual property boutique in New York City, held a postdoctoral fellowship at Weill Medical College of Cornell University and conducted bioinformatics research in cancer immunotherapy. She received her PhD from the Department of Microbiology and Immunology at the University of Arizona studying the efficacy of genetically modified tumor cell vaccines, with a minor in microbial pathogenesis.

Singh uses his insider’s knowledge of industry dynamics from his time as a medicinal chemist to help his clients develop strong legal strategies. He is a patent attorney with a focus on patent litigation, counseling, due diligence, patentability and clearance issues, and patent prosecution in the chemical, biotechnology and pharmaceutical industries.

Emery works on matters related to prosecution, due diligence and clearance in the biotechnology and pharmaceutical industries. He has a diverse background in biotechnology research, marketing, licensing and intellectual property. In law school, Emery focused his studies on intellectual property and entrepreneurship, which included coursework at the business school and multiple internships in technology transfer and biotechnology patent prosecution. He was one of three members of his class to receive the Certificate in Entrepreneurial Law.

Click here to learn more about Brownstein’s intellectual property team.